ALMS Insider Trading Activity and SEC Form 4 Filings
ALMS insider trading summary
Over the past 12 months, insiders at Alumis Inc. (ALMS) reported 99 open-market purchases worth $146.6M by 13 insiders and 13 sales worth $558K by 6 insiders on SEC Form 4. Net insider buying was $146.0M.
Latest ALMS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 2, 2026 | Sanam Pangali | Chief Legal Officer | Sell | $2K (332 @ $6.52) |
| Nov 2, 2026 | Jorn Drappa | Chief Medical Officer | Sell | $4K (593 @ $6.52) |
| Nov 2, 2026 | Roy C. Hardiman | Chief Business & Strategy Ofcr | Sell | $4K (652 @ $6.52) |
| Nov 2, 2026 | John R. Schroer | Chief Financial Officer | Sell | $5K (794 @ $6.52) |
| Nov 2, 2026 | Mark Christopher Bradley | Chief Development Officer | Sell | $4K (623 @ $6.52) |
| Nov 2, 2026 | David M Goldstein | Chief Scientific Officer | Sell | $4K (629 @ $6.52) |
| Aug 3, 2026 | John R. Schroer | Chief Financial Officer | Sell | $87K (3,282 @ $26.37) |
| Aug 3, 2026 | Sanam Pangali | Chief Legal Officer | Sell | $36K (1,364 @ $26.37) |
| Aug 3, 2026 | Jorn Drappa | Chief Medical Officer | Sell | $65K (2,447 @ $26.37) |
| Aug 3, 2026 | David M Goldstein | Chief Scientific Officer | Sell | $68K (2,596 @ $26.37) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.